How this shows up in interviews
Objection handling is the most role-played topic in sales interviews; negotiation questions are standard for AE roles.
"I'm a prospect and I say you're too expensive — go." They're testing process, not price defence. Don't defend value or offer a discount in your first breath: acknowledge, then explore — "Fair challenge — what are you comparing it against?" — work towards the true alternative's cost, then isolate. If invited to debrief: "'Too expensive' is usually a value or comparison problem underneath, so I explore before I respond."
"Tell me about a deal you lost." If you've never sold, you have no sales losses — and you must never invent one; experienced interviewers unpick fabricated deals in two follow-up questions. Use any real loss instead:
- a project that was cancelled
- a pitch or tender that went to someone else
- a funding bid that failed
- a job you didn't get
Structure it like a professional loss review — what actually happened, decided by whom, on what criteria — own your part without flagellation, and spend most of the answer on what you learned and changed afterwards. Never blame the other side or "politics". If it genuinely fits, the strongest ending is a no-decision loss: "nothing was chosen at all — which taught me why you have to sell the cost of inaction, not just the merits."
"How do you handle being ghosted?" Show a system, not hurt feelings: two or three spaced, value-adding follow-ups, then a warm break-up email to force a truthful answer either way — and a full pipeline so no single silence matters. Mention that a surprising share of break-up emails get replies.
"A buyer demands 30% off on the last day of the quarter. What do you do?" Name the tactic calmly (the end-of-quarter squeeze), then show discount hygiene: never concede without a get, ask what the 30% unlocks, trade scope or terms before price, and be genuinely willing to let the date pass. Quoting "how am I supposed to do that?" as your actual line lands well.
"An NHS customer says the clinicians will never adopt it. How do you respond?" Explore before answering: which clinicians, and what's the history — no champion, click-heavy workflow, or a failed pilot? Then answer the root: week-one time savings, a clinical champion co-designing the pilot, success criteria set with the sceptics, peer reference calls.
This doubles as a domain-credibility test — if you have any first-hand exposure to clinical settings or healthcare research (a placement, a project, clinical or care work), this is the moment to bring it in; if you don't, naming the three failure roots and their fixes is itself evidence you've studied how clinical adoption really works.
"How do you know when to ask for the business?" Closing is the natural end of good process: objections resolved and confirmed, trial closes coming back warm, mutual action plan down to its last rows — then a direct, unembarrassed ask. Add next-step discipline: every call ends with a calendared step, so the close surprises nobody.
"What's the difference between an objection and a brush-off?" Define all three categories: objections have specific content and get worked with LAER/LAARC; stalls are vague and get probed into either a real objection or a qualification decision; conditions (procurement, lock-ins, regulation) are facts you plan around, not argue with. Distinguishing them shows you'll spend pipeline time on winnable deals.
Cheat sheet
The process (LAARC): Listen → Acknowledge → Assess/Explore (+ isolate) → Respond → Confirm. Never respond to an objection you haven't explored. Objections are buying signals. Surface ≠ root.
Triage:
- Objection = specific obstacle → work it.
- Stall = vague delay → probe into an objection or qualify out.
- Condition = fact of their world (procurement, contracts, regulation) → meet it and plan around it.
The big nine, one-line handles:
- Too expensive → "Compared to what?" — cost the true alternative; isolate.
- No budget → whose budget, which year, what off-cycle funding; co-write the business case.
- Competitor incumbent → never criticise it; find the gap; wedge alongside; get the renewal date.
- Not a priority → find their actual priority and connect to it — or wait gracefully, with a date.
- Send me information → usually a stall (or occasionally a genuine request); agree + tailor + book the review call; no next step = brush-off.
- Tried and failed → explore the failure mode; differentiate against it specifically; peer reference.
- Clinicians won't adopt → which clinicians, why; champion + week-one time saving + co-designed pilot.
- Data protection / IG → buying signal; DPIA, DSPT, DTAC fluency; volunteer the DPO call.
- Procurement → a condition; map the route (framework vs tender) into the mutual action plan.
Negotiation:
- Never concede without a get.
- Anchor first, high, defensible.
- Discounts: never unasked, never free, shrinking concessions, scope before price, ask what it unlocks.
- Buyer plays: nibble (re-trade every extra), good cop/bad cop (meet the bad cop), quarter-end squeeze (hide your calendar; real deadlines only).
- Three dials: price, scope, terms.
- BATNA = your pipeline; set the walkaway in advance.
- Voss: tactical empathy, labels, calibrated how/what questions, "How am I supposed to do that?"
Closing:
- Process, not pressure — but you must ask, directly.
- Trial closes take temperature en route.
- Every call ends with a calendared next step.
- Mutual action plan on every serious deal (owners + dates, both sides, procurement and IG steps included).
- Quarter-end: the buyer's timeline beats your fiscal calendar.
- Ghosted → value-adding follow-ups ×2–3 → warm break-up email.
Losing:
- loss review every time (ask the buyer);
- lose graciously, keep the door open;
- the biggest competitor is no-decision — sell the cost of inaction from day one.
References & further reading
- Never Split the Difference — Chris Voss with Tahl Raz (2016). The negotiation book working sellers actually use: tactical empathy, labelling, calibrated questions and "How am I supposed to do that?" all come from here, with the FBI stories that make them stick.
- Objections: The Ultimate Guide for Mastering the Art and Science of Getting Past No — Jeb Blount (2018). The full treatment of why objections trigger a fear-of-rejection response and how emotional control, not clever scripts, gets you past no.
- The JOLT Effect: How High Performers Overcome Customer Indecision — Matthew Dixon & Ted McKenna (2022). Built on millions of recorded sales calls; the definitive work on no-decision losses and why de-risking the choice beats piling on urgency.
- Getting to Yes — Roger Fisher & William Ury (1981; updated editions). The Harvard classic that gave negotiation its vocabulary — BATNA, interests vs positions, principled negotiation — and the book Voss is arguing with.
- Secrets of Closing the Sale — Zig Ziglar (1984). Dated in style, permanent in substance: the five obstacles, closing as service to the buyer, and the conviction that you have to ask.
- You Can't Teach a Kid to Ride a Bike at a Seminar — David H. Sandler (1995; updated 2015). The Sandler Selling System — up-front contracts, going for the "no", never looking desperate — much of which underpins modern qualification discipline.
- "Stop Losing Sales to Customer Indecision" — Matthew Dixon & Ted McKenna, Harvard Business Review (2022). The JOLT research in article length; the fastest credible read on why 40–60% of deals die to inaction.
- 30 Minutes to President's Club (podcast). Relentlessly tactical, zero fluff; its negotiation and closing episodes (e.g. "The Negotiation Playbook") are working AEs trading exact talk tracks, and a good ear for how this module sounds in practice.